108 related articles for article (PubMed ID: 32589499)
21. DOPA-based paclitaxel-loaded liposomes with modifications of transferrin and alendronate for bone and myeloma targeting.
Chang Q; Geng R; Wang S; Qu D; Kong X
Drug Deliv; 2016 Nov; 23(9):3629-3638. PubMed ID: 27749106
[TBL] [Abstract][Full Text] [Related]
22. PEGylated hyaluronic acid-coated liposome for enhanced in vivo efficacy of sorafenib via active tumor cell targeting and prolonged systemic exposure.
Mo L; Song JG; Lee H; Zhao M; Kim HY; Lee YJ; Ko HW; Han HK
Nanomedicine; 2018 Feb; 14(2):557-567. PubMed ID: 29248675
[TBL] [Abstract][Full Text] [Related]
23. [Cell penetrating peptide TAT and brain tumor targeting peptide T7 dual modified liposome preparation and in vitro targeting evaluation].
Yuan DF; Zong TL; Gao HL; He Q
Yao Xue Xue Bao; 2015 Jan; 50(1):104-10. PubMed ID: 25924484
[TBL] [Abstract][Full Text] [Related]
24. Development of gelatin-coated nanoliposomes loaded with β-cyclodextrin/vitamin D
Ebrahimi A; Hamishehkar H; Amjadi S
Food Chem; 2023 Oct; 424():136346. PubMed ID: 37201470
[TBL] [Abstract][Full Text] [Related]
25. Development of Linker-Conjugated Nanosize Lipid Vesicles: A Strategy for Cell Selective Treatment in Breast Cancer.
Dey NS; Mukherjee B; Maji R; Satapathy BS
Curr Cancer Drug Targets; 2016; 16(4):357-72. PubMed ID: 26548758
[TBL] [Abstract][Full Text] [Related]
26. Study on the cellular internalization mechanisms and
Gu Y; Chen X; Zhang H; Wang H; Chen H; Huang S; Xu Y; Zhang Y; Wu X; Chen J
Drug Deliv; 2020 Dec; 27(1):161-169. PubMed ID: 31913730
[TBL] [Abstract][Full Text] [Related]
27. Systemic delivery of siRNA by T7 peptide modified core-shell nanoparticles for targeted therapy of breast cancer.
Yu MZ; Pang WH; Yang T; Wang JC; Wei L; Qiu C; Wu YF; Liu WZ; Wei W; Guo XY; Zhang Q
Eur J Pharm Sci; 2016 Sep; 92():39-48. PubMed ID: 27355138
[TBL] [Abstract][Full Text] [Related]
28. Bleomycin sulphate loaded nanostructured lipid particles augment oral bioavailability, cytotoxicity and apoptosis in cervical cancer cells.
Saini J; Bansal V; Chandra A; Madan J; Jain UK; Chandra R; Jain SM
Colloids Surf B Biointerfaces; 2014 Jun; 118():101-10. PubMed ID: 24732397
[TBL] [Abstract][Full Text] [Related]
29. Lung-targeting drug delivery system of baicalin-loaded nanoliposomes: development, biodistribution in rabbits, and pharmacodynamics in nude mice bearing orthotopic human lung cancer.
Wei Y; Liang J; Zheng X; Pi C; Liu H; Yang H; Zou Y; Ye Y; Zhao L
Int J Nanomedicine; 2017; 12():251-261. PubMed ID: 28096670
[TBL] [Abstract][Full Text] [Related]
30. Nanolipid-loaded Preyssler polyoxometalate: Synthesis, characterization and invitro inhibitory effects on HepG2 tumor cells.
Razavi SF; Bamoharram FF; Hashemi T; Shahrokhabadi K; Davoodnia A
Toxicol In Vitro; 2020 Oct; 68():104917. PubMed ID: 32580012
[TBL] [Abstract][Full Text] [Related]
31. Anticancer activity of polymeric nanoparticles containing linoleic acid-SN38 (LA-SN38) conjugate in a murine model of colorectal cancer.
Cheng G; Zhang X; Chen Y; Lee RJ; Wang J; Yao J; Zhang Y; Zhang C; Wang K; Yu B
Colloids Surf B Biointerfaces; 2019 Sep; 181():822-829. PubMed ID: 31247407
[TBL] [Abstract][Full Text] [Related]
32. Surface-engineered nanoliposomes with lipidated and non-lipidated peptide-dendrimeric scaffold for efficient transdermal delivery of a therapeutic agent: Development, characterization, toxicological and preclinical performance analyses.
Manikkath J; Parekh HS; Mutalik S
Eur J Pharm Biopharm; 2020 Nov; 156():97-113. PubMed ID: 32911066
[TBL] [Abstract][Full Text] [Related]
33. Sorafenib-Loaded Long-Circulating Nanoliposomes for Liver Cancer Therapy.
Ye H; Zhou L; Jin H; Chen Y; Cheng D; Jiang Y
Biomed Res Int; 2020; 2020():1351046. PubMed ID: 32461962
[TBL] [Abstract][Full Text] [Related]
34. Surface-engineered nanoliposomes by chelating ligands for modulating the neurotoxicity associated with β-amyloid aggregates of Alzheimer's disease.
Mufamadi MS; Choonara YE; Kumar P; Modi G; Naidoo D; Ndesendo VM; du Toit LC; Iyuke SE; Pillay V
Pharm Res; 2012 Nov; 29(11):3075-89. PubMed ID: 22584945
[TBL] [Abstract][Full Text] [Related]
35. Hyaluronic acid-tagged silica nanoparticles in colon cancer therapy: therapeutic efficacy evaluation.
Liu K; Wang ZQ; Wang SJ; Liu P; Qin YH; Ma Y; Li XC; Huo ZJ
Int J Nanomedicine; 2015; 10():6445-54. PubMed ID: 26491300
[TBL] [Abstract][Full Text] [Related]
36. Preparation, characterization and in vitro efficacy of magnetic nanoliposomes containing the artemisinin and transferrin.
Gharib A; Faezizadeh Z; Mesbah-Namin SA; Saravani R
Daru; 2014 May; 22(1):44. PubMed ID: 24887240
[TBL] [Abstract][Full Text] [Related]
37. Doxorubicin and siRNA-PD-L1 co-delivery with T7 modified ROS-sensitive nanoparticles for tumor chemoimmunotherapy.
Wan WJ; Qu CX; Zhou YJ; Zhang L; Chen MT; Liu Y; You BG; Li F; Wang DD; Zhang XN
Int J Pharm; 2019 Jul; 566():731-744. PubMed ID: 31212055
[TBL] [Abstract][Full Text] [Related]
38. T7 Peptide-Conjugated Lipid Nanoparticles for Dual Modulation of Bcl-2 and Akt-1 in Lung and Cervical Carcinomas.
Cheng X; Yu D; Cheng G; Yung BC; Liu Y; Li H; Kang C; Fang X; Tian S; Zhou X; Liu Q; Lee RJ
Mol Pharm; 2018 Oct; 15(10):4722-4732. PubMed ID: 30138565
[TBL] [Abstract][Full Text] [Related]
39. pH-Sensitive carboxymethyl chitosan-modified cationic liposomes for sorafenib and siRNA co-delivery.
Yao Y; Su Z; Liang Y; Zhang N
Int J Nanomedicine; 2015; 10():6185-97. PubMed ID: 26491291
[TBL] [Abstract][Full Text] [Related]
40. Anti-proliferate and apoptosis triggering potential of methotrexate-transferrin conjugate encapsulated PLGA nanoparticles with enhanced cellular uptake by high-affinity folate receptors.
Parmar A; Jain A; Uppal S; Mehta SK; Kaur K; Singh B; Sandhir R; Sharma S
Artif Cells Nanomed Biotechnol; 2018; 46(sup2):704-719. PubMed ID: 29745729
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
